Skip to main content
Tech.euFundingExplorerBeta

Nemaura Medical

Nemaura Medical is a Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT.

Nemaura Medical has raised €11M across 2 funding rounds, most recently a Debt round in Aug 2023. Based in Loughborough, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€11M
€10,655,620
Funding rounds
2
Investors
0
distinct backers
Active since
2022-05
latest 2023-08

Funding by year

EUR raised per year
Nemaura Medical — funding by year — interactive chart.
Data table
Nemaura Medical — funding by year
2022€4.7M
2023€6.0M

Signals

Medium confidence
Raise-next likelihood10
base rate 45% for Debt
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2023-08-18Debt€6.0M—View deal →
2022-05-26Other€4.7M—View deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData